Searched for
BIOSCIENCES INNOVATION
Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...- Ashoka University appoints Professor Rishikesha T. Krishnan as its next vice-chancellorAshoka University has appointed Professor Rishikesha T. Krishnan as its next Vice-Chancellor, effective August 1, 2026. A distinguished sch...
- Several red flags emerge as SpaceX IPO hawks Elon Musk's Mars dreamSpaceX's bold Mars vision faces scientific doubts. Experts highlight engineering challenges and human biology unknowns. Colonizing Mars pre...
- As AI shifts from training to inference, Intel moves up the stackIntel is changing its AI strategy. The company is now focusing on building complete AI systems and infrastructure, not just chips. This mov...
- What AI’s entry into de-extinction research says about modern biologyArtificial intelligence is increasingly being used to process complex genetic data, enabling new approaches in biological research. This sh...
- Shastra VC launches $100 million fund to back deeptech, AI startupsThe Bengaluru-based firm said the new vehicle will invest between $500,000 and $3 million in IP-led firms across these sectors. The launch ...
- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- IIT Roorkee inaugurates Ashok Soota Molecular Medicine Facility at BSBE to advance translational biomedical researchIIT Roorkee has launched the Ashok Soota Molecular Medicine Facility, a state-of-the-art platform for advanced biomedical research, drug di...
- Veterinary vaccine firms form association for collaboration with policymakersIndia's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have formed the Veterinary Vaccin...
- Anthem Biosciences IPO allotment out today; GMP strong ahead of listingAnthem Biosciences IPO allotment date: The allotment for Anthem Biosciences IPO is now complete. Investors can check their status on KFin T...
- IIT Kanpur & Wadhwani Foundation to establish Wadhwani School of Advanced Artificial Intelligence & Intelligent SystemsIIT Kanpur, in partnership with the Wadhwani Foundation, is launching the Wadhwani School of Advanced Artificial Intelligence and Intellige...
- DeepTech’s steady rise: A promising frontier for VCs and investorsFor venture capital firms like Aeravti Ventures and Capital-A, DeepTech is not just a promising investment category—it represents the futur...
- Anthem Biosciences appoints JM Financial, Citi, JP Morgan as bankers for IPOAnthem Biosciences has selected JM Financial as the lead banker for its IPO, along with Citi and JP Morgan. The company plans to raise Rs 3...
- Hester Biosciences board approves scheme of amalgamation and arrangementFor merger of Diavetra, GAFL and Hester Mauritius into Hester India, no shares of Hester India will be issued on amalgamation, Hester Biosc...
- GVK Biosciences, Onconova Therapeutics ink pact to develop cancer drugsThe Hyderabad-based firm and Onconova have entered into a JV to develop new drugs for cancer, GVK Biosciences said in a statement.
- Hester Biosciences acquires Innoves Animal HealthA BTA has been entered between Hester and Innoves. Hester acquired the products, the brands and the marketing network of Innoves
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 mHyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...
- Indian drug cos prepare a peptide mixAs blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
- Ranbaxy, Jupiter Bioscience enter into marketing tie-upRanbaxy Laboratories is about to enter into a 10-year co-marketing agreement with Jupiter Bioscience to tap the $6-billion global peptide p...
Load More
